Lan Chen

1.8k total citations
52 papers, 1.3k citations indexed

About

Lan Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Lan Chen has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Immunology. Recurrent topics in Lan Chen's work include Ion Transport and Channel Regulation (5 papers), CAR-T cell therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Lan Chen is often cited by papers focused on Ion Transport and Channel Regulation (5 papers), CAR-T cell therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Lan Chen collaborates with scholars based in China, United States and France. Lan Chen's co-authors include Sadis Matalon, Asta Jurkuvenaite, Ben Gross, Yanan Hu, Sha Ha, Brian V. Falcone, Suzanne Walker, Deborah Walker, James F. Collawn and Rebecca F. Goldstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Lan Chen

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Chen China 21 606 301 209 161 146 52 1.3k
Santosh Renuse United States 27 1.2k 2.0× 123 0.4× 182 0.9× 154 1.0× 194 1.3× 73 2.1k
Eric Meldrum United Kingdom 13 851 1.4× 391 1.3× 112 0.5× 172 1.1× 70 0.5× 22 1.5k
Jeng‐Wei Lu Taiwan 24 759 1.3× 109 0.4× 159 0.8× 177 1.1× 210 1.4× 95 1.6k
Darren W. Sexton United Kingdom 21 534 0.9× 156 0.5× 140 0.7× 358 2.2× 74 0.5× 46 1.4k
Patricia M. Scott United States 16 628 1.0× 217 0.7× 261 1.2× 113 0.7× 166 1.1× 24 1.3k
Shih‐Chieh Chang Taiwan 21 483 0.8× 514 1.7× 81 0.4× 95 0.6× 272 1.9× 77 1.5k
Zai Wang China 21 410 0.7× 94 0.3× 387 1.9× 114 0.7× 93 0.6× 56 1.3k
Hsuan Liu Taiwan 22 1.1k 1.9× 152 0.5× 130 0.6× 199 1.2× 269 1.8× 69 1.9k
Jian Ruan China 24 791 1.3× 238 0.8× 53 0.3× 125 0.8× 137 0.9× 94 1.5k
Yiming Wu China 19 1.0k 1.7× 231 0.8× 62 0.3× 225 1.4× 197 1.3× 71 1.6k

Countries citing papers authored by Lan Chen

Since Specialization
Citations

This map shows the geographic impact of Lan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Chen more than expected).

Fields of papers citing papers by Lan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Chen. The network helps show where Lan Chen may publish in the future.

Co-authorship network of co-authors of Lan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Chen. A scholar is included among the top collaborators of Lan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Chen. Lan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Tian, Chen Zhao, Lan Chen, et al.. (2024). Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines. Human Vaccines & Immunotherapeutics. 20(1). 2423466–2423466. 1 indexed citations
2.
Chen, Lan, Hao Wu, Yangbo Tang, et al.. (2023). Cell therapy in end-stage liver disease: replace and remodel. Stem Cell Research & Therapy. 14(1). 141–141. 20 indexed citations
3.
Liu, Meijing, Cuicui Lv, Lan Chen, et al.. (2022). Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo. Technology in Cancer Research & Treatment. 21. 2213875112–2213875112. 3 indexed citations
4.
Chi, Xiaojing, Xinhui Zhang, Yanying Yu, et al.. (2022). An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants. Signal Transduction and Targeted Therapy. 7(1). 44–44. 39 indexed citations
5.
Li, Wei, Yan Zhang, Ronghui Li, et al.. (2022). A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice. Frontiers in Immunology. 13. 877022–877022. 2 indexed citations
6.
Ravindran, Avinash, Radleigh G. Santos, Lan Chen, et al.. (2021). CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope. The Journal of Experimental Medicine. 218(10). 32 indexed citations
7.
Lv, Xiaodan, Lan Chen, Junhua Fan, et al.. (2021). The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population. International Journal of General Medicine. Volume 14. 9163–9172. 1 indexed citations
8.
Sima, Livia Elena, Bakhtiyor Yakubov, Sheng Zhang, et al.. (2019). Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Molecular Cancer Therapeutics. 18(6). 1057–1068. 17 indexed citations
9.
Zhou, Ping, Qiong Xiao, Lan Chen, et al.. (2019). Effects of Huaiqihuang Granules adjuvant therapy in children with primary nephrotic syndrome. Open Life Sciences. 14(1). 519–527. 2 indexed citations
10.
11.
Walsh, Scott R., Donald Bastin, Lan Chen, et al.. (2018). Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity. Journal of Clinical Investigation. 129(2). 518–530. 28 indexed citations
12.
Nguyen, Andrew, Louisa Ho, Samuel T. Workenhe, et al.. (2018). HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants. Cell Reports. 24(3). 642–654. 22 indexed citations
13.
Li, Shenghua, Jinpin Li, Lan Chen, & Jingli Liu. (2018). miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A. Medical Hypotheses. 117. 21–27. 18 indexed citations
14.
Gao, Meili, Yongfei Li, Xiaochang Xue, et al.. (2014). Impact of AhR, CYP1A1 and GSTM1 Genetic Polymorphisms on TP53 R273G Mutations in Individuals Exposed to Polycyclic Aromatic Hydrocarbons. Asian Pacific Journal of Cancer Prevention. 15(6). 2699–2705. 11 indexed citations
15.
Xiang, Zichun, Richard Gonzalez, Lili Ren, et al.. (2012). Prevalence and clinical characteristics of human respiratory syncytial virus in Chinese adults with acute respiratory tract infection. Journal of Medical Virology. 85(2). 348–353. 16 indexed citations
16.
Lazrak, Ahmed, Lan Chen, Asta Jurkuvenaite, et al.. (2011). Regulation of Alveolar Epithelial Na+ Channels by ERK1/2 in Chlorine-Breathing Mice. American Journal of Respiratory Cell and Molecular Biology. 46(3). 342–354. 40 indexed citations
17.
Porter, Kevin R., Daniel Ewing, Lan Chen, et al.. (2011). Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine. Vaccine. 30(2). 336–341. 58 indexed citations
18.
Ren, Lili, Richard Gonzalez, Jin Xu, et al.. (2010). Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing, China. Journal of Medical Virology. 83(2). 291–297. 60 indexed citations
19.
Ren, Lili, Richard Gonzalez, Zhengde Xie, et al.. (2010). Saffold Cardioviruses of 3 Lineages in Children with Respiratory Tract Infections, Beijing, China. Emerging infectious diseases. 16(7). 1158–1161. 20 indexed citations
20.
Chen, Lan, Yang Yang, Jun Han, et al.. (2007). Removal of the Glycosylation of Prion Protein Provokes Apoptosis in SF126. BMB Reports. 40(5). 662–669. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santosh Renuse Breakdown of academic impact, for papers by Eric Meldrum Breakdown of academic impact, for papers by Jeng‐Wei Lu Breakdown of academic impact, for papers by Darren W. Sexton Breakdown of academic impact, for papers by Patricia M. Scott Breakdown of academic impact, for papers by Shih‐Chieh Chang Breakdown of academic impact, for papers by Zai Wang Breakdown of academic impact, for papers by Hsuan Liu Breakdown of academic impact, for papers by Jian Ruan Breakdown of academic impact, for papers by Yiming Wu
Rankless by CCL
2026